[Comparison of different laryngeal preservation strategies based on chemoradiotherapy in locally advanced hypopharyngeal carcinoma].

Xi Luo, Shiran Sun, Yi Xu, Xiaodong Huang, Kai Wang, Runye Wu, Jingbo Wang, Ye Zhang, Jianghu Zhang, Xuesong Chen, Yuan Qu, Jingwei Luo, Junlin Yi
{"title":"[Comparison of different laryngeal preservation strategies based on chemoradiotherapy in locally advanced hypopharyngeal carcinoma].","authors":"Xi Luo, Shiran Sun, Yi Xu, Xiaodong Huang, Kai Wang, Runye Wu, Jingbo Wang, Ye Zhang, Jianghu Zhang, Xuesong Chen, Yuan Qu, Jingwei Luo, Junlin Yi","doi":"10.13201/j.issn.2096-7993.2023.09.005","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b>This study aimed to evaluate the clinical features and treatment outcomes of the value of response-adapted treatment following radiotherapy and induction chemotherapy follwing subsequent comprehensive therapy in patients with resectable locally advanced hypopharyngeal carcinoma. <b>Methods:</b>This cohort study was conducted from September 2010 to September 2020 in our hospital, 231 patients pathologically confirmed stage Ⅲ and ⅣB resectable locally advanced hypopharyngeal carcinoma included. For the IC-directed ART strategy, IC is used to select good candidates to receive radical RT or CCRT, and others undergo surgery. He response-adapted strategy was determined based on the primary tumor response, which was evaluated at a dose of 50 Gy. If the response reached complete response or partial response(more than 80% tumor regression), patients received radical RT or CCRT; otherwise, they received surgery, if possible, at 4 to 6 weeks after RT. The end points of the study were OS(overall survival), progression free survival(PFS), locoregional recurrence-free survival(LRRFS) and LDFS. <b>Results:</b>In IC-directed group, 75.0%(57/76) patients reached PR after 2 cycles of induction chemotherapy. While in RT-directed group, 70.3%(109/155) patients reached large PR at dose of 50 Gy. The median interquartile range follow-up period of the whole cohort was 63.8 months. The 5-year OS, PFS, LRRFS and SFL of the whole cohort were 47.9%、39.6%、44.3% and 36.2%, respectively. In evaluations based on the different treatment strategies, the 5-year OS and SFL were 51.3% versus 37.0%(<i>HR</i> 0.67; 95%<i>CI</i> 0.43-1.05; <i>P</i>=0.07) and 27.8% versus 39.8%(<i>HR</i> 0.68; 95%<i>CI</i> 0.46-0.99; <i>P</i>=0.04) between IC-directed and RT-directed groups. In additional, surgery complications did not significantly differ between these two groups. <b>Conclusion:</b>In this cohort study, the response-adapted strategy based on an early RT response facilitated better treatment tailoring, and higher laryngeal preservation compared with IC-directed strategies. This approach could provide a feasible laryngeal preservation strategy in patients with resectable locally advanced hypopharyngeal carcinoma.</p>","PeriodicalId":18104,"journal":{"name":"Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery","volume":"37 9","pages":"708-714"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10722127/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13201/j.issn.2096-7993.2023.09.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective:This study aimed to evaluate the clinical features and treatment outcomes of the value of response-adapted treatment following radiotherapy and induction chemotherapy follwing subsequent comprehensive therapy in patients with resectable locally advanced hypopharyngeal carcinoma. Methods:This cohort study was conducted from September 2010 to September 2020 in our hospital, 231 patients pathologically confirmed stage Ⅲ and ⅣB resectable locally advanced hypopharyngeal carcinoma included. For the IC-directed ART strategy, IC is used to select good candidates to receive radical RT or CCRT, and others undergo surgery. He response-adapted strategy was determined based on the primary tumor response, which was evaluated at a dose of 50 Gy. If the response reached complete response or partial response(more than 80% tumor regression), patients received radical RT or CCRT; otherwise, they received surgery, if possible, at 4 to 6 weeks after RT. The end points of the study were OS(overall survival), progression free survival(PFS), locoregional recurrence-free survival(LRRFS) and LDFS. Results:In IC-directed group, 75.0%(57/76) patients reached PR after 2 cycles of induction chemotherapy. While in RT-directed group, 70.3%(109/155) patients reached large PR at dose of 50 Gy. The median interquartile range follow-up period of the whole cohort was 63.8 months. The 5-year OS, PFS, LRRFS and SFL of the whole cohort were 47.9%、39.6%、44.3% and 36.2%, respectively. In evaluations based on the different treatment strategies, the 5-year OS and SFL were 51.3% versus 37.0%(HR 0.67; 95%CI 0.43-1.05; P=0.07) and 27.8% versus 39.8%(HR 0.68; 95%CI 0.46-0.99; P=0.04) between IC-directed and RT-directed groups. In additional, surgery complications did not significantly differ between these two groups. Conclusion:In this cohort study, the response-adapted strategy based on an early RT response facilitated better treatment tailoring, and higher laryngeal preservation compared with IC-directed strategies. This approach could provide a feasible laryngeal preservation strategy in patients with resectable locally advanced hypopharyngeal carcinoma.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[局部晚期下咽癌化疗基础上的不同保喉策略比较]。
目的:本研究旨在评估可切除的局部晚期下咽癌患者在放疗和诱导化疗后接受反应适应性治疗的临床特征和治疗效果。方法:该队列研究于2010年9月至2020年9月在我院进行,共纳入231例经病理证实的Ⅲ期和ⅣB期可切除局部晚期下咽癌患者。在IC引导的ART策略中,利用IC选择好的候选者接受根治性RT或CCRT,其他人接受手术。他的反应适应策略是根据原发肿瘤反应确定的,以50 Gy的剂量进行评估。如果反应达到完全反应或部分反应(肿瘤消退超过80%),患者将接受根治性RT或CCRT治疗;否则,如果可能,患者将在RT治疗后4至6周接受手术治疗。研究终点为OS(总生存期)、无进展生存期(PFS)、无局部复发生存期(LRRFS)和LDFS。和 LDFS。结果:在IC导向组中,75.0%(57/76)的患者在2个周期的诱导治疗后达到PR。患者在两个周期的诱导化疗后达到PR。而在RT导向组中,70.3%(109/155)而在RT引导组中,70.3%(109/155)的患者在剂量为50 Gy时达到大PR。整个组群的中位四分位距随访时间为63.8个月。全组患者的5年OS、PFS、LRRFS和SFL分别为47.9%、39.6%、44.3%和36.2%。在基于不同治疗策略的评估中,5年OS和SFL分别为51.3%对37.0%(HR 0.67; 95%CI 0.43-1.05; P=0.07)和27.8%对39.0%(HR 0.67; 95%CI 0.43-1.05; P=0.07)。和27.8%对39.8%(HR 0.68; 95%CI 0.46-0.99; P=0.04)。在IC引导组和RT引导组之间的差异也不大。此外,手术并发症在两组之间没有明显差异。结论:在这项队列研究中,与IC导向策略相比,基于早期RT反应的反应适应策略能更好地调整治疗方案,保留更多喉部。这种方法可为可切除的局部晚期下咽癌患者提供一种可行的保喉策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Clinical characteristics and efficacy of oropharyngeal carcinoma with secondary primary tumor]. [Research progress on the treatment improvement of HPV-associated oropharyngeal cancer]. [Analysis of efficacy and prognosis of neoadjuvant chemotherapy and (or) surgery plus radiotherapy for hypopharyngeal squamous cell carcinoma]. [TCOF1 Gene variation in Treacher Collins syndrome and evaluation of speech rehabilitation after bone bridge surgery]. [Diffuse large B-cell lymphoma of thyroid invading the superior mediastinum with hashimoto's thyroiditis: a case report and literature review].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1